These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28499782)

  • 1. Systemic reactions to immunotherapy during mountain cedar season: implications for seasonal dose adjustment.
    Wong PH; Quinn JM; Gomez RA; Webb CN
    J Allergy Clin Immunol Pract; 2017; 5(5):1438-1439.e1. PubMed ID: 28499782
    [No Abstract]   [Full Text] [Related]  

  • 2. The mountain cedar model in clinical trials of seasonal allergic rhinoconjunctivitis.
    Andrews CP; Ratner PH; Ehler BR; Brooks EG; Pollock BH; Ramirez DA; Jacobs RL
    Ann Allergy Asthma Immunol; 2013 Jul; 111(1):9-13. PubMed ID: 23806453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaphylaxis caused by allergen sublingual immunotherapy?
    André C; Fadel R
    Allergy; 2007 Oct; 62(10):1220-1. PubMed ID: 17845597
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of risk factors for systemic adverse reactions to SCIT with natural depot allergen extracts: a retrospective study.
    Asero R
    Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):211-7. PubMed ID: 26549339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are Allergen Immunotherapy Dose Adjustments Needed for Local Reactions, Peaks of Season, or Gaps in Treatment?
    Epstein TE; Tankersley MS
    J Allergy Clin Immunol Pract; 2017; 5(5):1227-1233. PubMed ID: 28709818
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical trial shows sublingual immunotherapy to be effective for treatment of children with grass pollen allergy.
    Wilkinson J
    Immunotherapy; 2012 Nov; 4(11):1091-2. PubMed ID: 23194357
    [No Abstract]   [Full Text] [Related]  

  • 7. Circadian and seasonal variations in subcutaneous allergen immunotherapy reactions.
    McMurray JC; Waters AM; Macomb CV; Brooks DI; Schwartz DJ
    Ann Allergy Asthma Immunol; 2021 Nov; 127(5):595-596. PubMed ID: 34380067
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of allergen immunotherapy studies shows increased clinical efficacy in highly symptomatic patients.
    Howarth P; Malling HJ; Molimard M; Devillier P
    Allergy; 2012 Mar; 67(3):321-7. PubMed ID: 22142377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated Up-Dosing of Subcutaneous Immunotherapy with a Registered Allergoid Birch Pollen Preparation.
    Buczyłko K; van der Werf JF; Boot D; van Ree R
    Int Arch Allergy Immunol; 2017; 172(3):183-186. PubMed ID: 28380494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular sensitization patterns and influence of molecular diagnosis in immunotherapy prescription in children sensitized to both grass and olive pollen.
    Martínez-Cañavate Burgos A; Torres-Borrego J; Molina Terán AB; Corzo JL; García BE; Rodríguez Pacheco R; Moreno Aguilar C; Dávila I
    Pediatr Allergy Immunol; 2018 Jun; 29(4):369-374. PubMed ID: 29369414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy?
    Witten M; Malling HJ; Blom L; Poulsen BC; Poulsen LK
    J Allergy Clin Immunol; 2013 Nov; 132(5):1248-1252.e5. PubMed ID: 24035151
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sublingual immunotherapy in children with grass pollen induced allergic rhinoconjunctivitis].
    Wolthers OD; Høst A; Frederiksen B; Halken S
    Ugeskr Laeger; 2012 Aug; 174(35):1989-92. PubMed ID: 22929576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaphylaxis caused by in-season switchover of sublingual immunotherapy formulation.
    Hsiao KC; Smart J
    Pediatr Allergy Immunol; 2014 Nov; 25(7):714-5. PubMed ID: 25200920
    [No Abstract]   [Full Text] [Related]  

  • 14. Usefulness of sublingual immunotherapy in children.
    Bufe A
    Drugs Today (Barc); 2008 Dec; 44 Suppl B():61-3. PubMed ID: 19221622
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent advances in specific immunotherapy for allergic rhinitis.
    Bousquet J; Hejjaoui A; Michel FB
    Clin Exp Allergy; 1991 Jan; 21 Suppl 1():259-61. PubMed ID: 2032157
    [No Abstract]   [Full Text] [Related]  

  • 16. Ultra short pre-seasonal subcutaneous immunotherapy and pre-coseasonal sublingual immunotherapy for pollen allergy: an evaluation of patient's preference in real life.
    Manzotti G; Pappacoda A; Dimatteo M; Scolari C; Riario-Sforza GG; Incorvaia C
    Eur Ann Allergy Clin Immunol; 2013 Aug; 45(4):138-43. PubMed ID: 24067339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of sublingual grass pollen immunotherapy after anaphylaxis.
    Nichani JR; de Carpentier J
    J Laryngol Otol; 2009 Jun; 123(6):683-4. PubMed ID: 18501039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An extract of Timothy-grass pollen used as sublingual immunotherapy for summer hay fever.
    Kay AB
    Drugs Today (Barc); 2007 Dec; 43(12):841-8. PubMed ID: 18174969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic Reactions in Pediatric Patients Receiving Standardized Allergen Subcutaneous Immunotherapy with and without Seasonal Dose Adjustment.
    Albuhairi S; Sare T; Lakin P; El Khoury K; Crestani E; Schneider LC; Anzaldi R; Patterson A; Rachid R
    J Allergy Clin Immunol Pract; 2018; 6(5):1711-1716.e4. PubMed ID: 29339129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.
    Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.